US 7456180
Piperazine derivatives and their use as therapeutic agents
granted A61KA61K31/00A61K31/501
Quick answer
US patent 7456180 (Piperazine derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/00, A61K31/501, A61K31/551, A61P